![thumbnail image](https://custom-images.strikinglycdn.com/res/hrscywv4p/image/upload/c_limit,fl_lossy,h_630,w_1200,f_auto,q_auto/1229618/952253_412109.png)
![broken image](http://custom-images.strikinglycdn.com/res/hrscywv4p/image/upload/c_limit,fl_lossy,h_300,w_300,f_auto,q_100/1229618/832832_258578.png)
Developing a novel technology platform for the safe and effective expression of immunotherapies within solid tumors
Salspera is a clinical phase company, with a proprietary platform technology enabling the non-toxic delivery of immunotherapies into the solid tumor microenvironment. Salspera's novel therapeutic constructs act as smart, guided, micro-factories, manufacturing highly potent immunotherapies within primary tumors and metastases. Together with other effective mechanisms of action, Salspera's therapies have shown efficacy and exceptional safety in solid tumors.